Post-transplant lymphoproliferative disorders

Vikas R. Dharnidharka, Angela C. Webster, Olivia M. Martinez, Jutta K. Preiksaitis, Veronique Leblond, Sylvain Choquet

Research output: Contribution to journalArticlepeer-review

72 Scopus citations

Abstract

Post-transplant lymphoproliferative disorders (PTLDs) are a group of conditions that involve uncontrolled proliferation of lymphoid cells as a consequence of extrinsic immunosuppression after organ or haematopoietic stem cell transplant. PTLDs show some similarities to classic lymphomas in the non-immunosuppressed general population. The oncogenic Epstein-Barr virus (EBV) is a key pathogenic driver in many early-onset cases, through multiple mechanisms. The incidence of PTLD varies with the type of transplant; a clear distinction should therefore be made between the conditions after solid organ transplant and after haematopoietic stem cell transplant. Recipient EBV seronegativity and the intensity of immunosuppression are among key risk factors. Symptoms and signs depend on the localization of the lymphoid masses. Diagnosis requires histopathology, although imaging techniques can provide additional supportive evidence. Pre-emptive intervention based on monitoring EBV levels in blood has emerged as the preferred strategy for PTLD prevention. Treatment of established disease includes reduction of immunosuppression and/or administration of rituximab (a B cell-specific antibody against CD20), chemotherapy and EBV-specific cytotoxic T cells. Despite these strategies, the mortality and morbidity remains considerable. Patient outcome is influenced by the severity of presentation, treatment-related complications and risk of allograft loss. New innovative treatment options hold promise for changing the outlook in the future.

Original languageEnglish
Article number15088
JournalNature Reviews Disease Primers
Volume2
DOIs
StatePublished - Jan 28 2016

Fingerprint Dive into the research topics of 'Post-transplant lymphoproliferative disorders'. Together they form a unique fingerprint.

Cite this